Phase 2 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with multiple myeloma (a type of blood cancer) confirmed by a specific protein marker, and there are no longer any treatment options available to cure it (including stem cell transplants).
- You have not been able to reach complete remission (where no cancer is detected) after trying at least 4 different combination treatment plans.
- Your cancer has come back a second or third time, you are in remission, but you cannot receive a donor stem cell transplant due to your age, other health conditions, or no matching donor being available.
- Your cancer came back less than 1 year after your last chemotherapy treatment ended.
- Your cancer came back or is still present after a previous stem cell transplant (using your own or a donor's cells), you have had at least 1 other treatment, and you are not able to have a donor stem cell transplant.
- You still have signs of cancer remaining after your first round of treatment and are not eligible for a stem cell transplant using your own cells.
- Your doctor expects you to live for more than 12 weeks.
- Your kidney function is within an acceptable range (confirm with trial site).
- Your liver enzyme levels are within an acceptable range (confirm with trial site).
- Your bilirubin (a liver-related substance in your blood) is at an acceptable level (confirm with trial site).
- If your cancer has come back after any stem cell transplant, you may be eligible regardless of what other treatments you have had.
- You have suitable veins to allow a blood-collection procedure called apheresis, and no health reasons that would prevent it.
- You are willing and able to give your informed consent to participate.
Who may not be able to join:
- You are pregnant or currently breastfeeding.
- You have an active infection that is not under control.
- You have an active hepatitis B or hepatitis C infection.
- You are currently taking steroid medications by mouth or injection (note: steroid inhalers are generally allowed).
- You have previously received a related type of gene-modified immune cell therapy called CAR-T cell therapy targeting the same area.
- You have any other serious medical condition that is not under control and would make it unsafe to participate (confirm with trial site).
- You are living with HIV.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients with treatment related adverse effect
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.